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Summary
Background Contacts of tuberculosis index cases are at increased risk of developing tuberculosis. Screening, preventive 
therapy, and surveillance for tuberculosis are underused interventions in contacts, particularly adults. We developed 
a score to predict risk of tuberculosis in adult contacts of tuberculosis index cases.
Methods In 2002–06, we recruited contacts aged 15 years or older of index cases with pulmonary tuberculosis who 
lived in desert shanty towns in Ventanilla, Peru. We followed up contacts for tuberculosis until February, 2016. We 
used a Cox proportional hazards model to identify index case, contact, and household risk factors for tuberculosis 
from which to derive a score and classify contacts as low, medium, or high risk. We validated the score in an urban 
community recruited in Callao, Peru, in 2014–15.
Findings In the derivation cohort, we identified 2017 contacts of 715 index cases, and median follow-up was 10·7 years 
(IQR 9·5–11·8). 178 (9%) of 2017 contacts developed tuberculosis during 19 147 person-years of follow-up (incidence 
0·93 per 100 person-years, 95% CI 0·80–1·08). Risk factors for tuberculosis were body-mass index, previous 
tuberculosis, age, sustained exposure to the index case, the index case being in a male patient, lower community 
household socioeconomic position, indoor air pollution, previous tuberculosis among household members, and 
living in a household with a low number of windows per room. The 10-year risks of tuberculosis in the low-risk, 
medium-risk, and high-risk groups were, respectively, 2·8% (95% CI 1·7–4·4), 6·2% (4·8–8·1), and 20·6% 
(17·3–24·4). The 535 (27%) contacts classified as high risk accounted for 60% of the tuberculosis identified during 
follow-up. The score predicted tuberculosis independently of tuberculin skin test and index-case drug sensitivity 
results. In the external validation cohort, 65 (3%) of 1910 contacts developed tuberculosis during 3771 person-years of 
follow-up (incidence 1·7 per 100 person-years, 95% CI 1·4–2·2). The 2·5-year risks of tuberculosis in the low-risk, 
medium-risk, and high-risk groups were, respectively, 1·4% (95% CI 0·7–2·8), 3·9% (2·5–5·9), and 8·6%· (5·9–12·6). 
Interpretation Our externally validated risk score could predict and stratify 10-year risk of developing tuberculosis in 
adult contacts, and could be used to prioritise tuberculosis control interventions for people most likely to benefit.
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Health Trials consortium, Bill & Melinda Gates Foundation, Imperial College National Institutes of Health Research 
Biomedical Research Centre, Foundation for Innovative New Diagnostics, Sir Halley Stewart Trust, WHO, TB 
REACH, and Innovation for Health and Development. 
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Introduction
Contacts of people with tuberculosis are at high risk of 
also developing tuberculosis.1 In low-income and middle-
income countries, WHO recommends investigation of 
contacts in all households of index cases with pulmonary 
tuberculosis. Investigation should involve screening and 
surveillance, with the aim of promptly diagnosing tuber-
culosis and providing preventive therapy for contacts 
judged to be at the highest risk.2 However, resources for 
contact investigation are often limited in national 
tuberculosis programmes, and adult contacts are rarely 
prioritised and frequently do not complete screening or 
take preventive therapy.3 Furthermore, the tests for latent 
tuberculosis infection that are commonly used to guide 
prescription of preventive therapy, such as the tuberculin 
skin test (TST) and interferon-γ-release assays, are 
technically and logistically complicated.4,5 These factors 
lead to difficulties in assessing who has latent 
tuberculosis or, when infection is confirmed, who is at 
high risk of progression to disease and, therefore, most 
likely to benefit from preventive therapy. 
International guidelines generally recommend that 
only contacts younger than 5 years or those who have 
HIV infection should receive preventive therapy. To end 
the tuberculosis epidemic, however, there is widespread 
recognition that use of preventive therapy needs to be 
scaled up and to target more effectively people at high 
risk of developing tuberculosis.4,6 Contacts of patients 
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with tuberculosis comprise one such group, but have 
heterogeneous risk, making effective and targeted use of 
preventive therapy challenging.
Several factors associated with index cases, households, 
and contacts are established for risk of latent tuberculosis 
and progression to disease among contacts.7 In this study 
we aimed to use these factors to derive a score to predict 
the risk of tuberculosis in adult contacts. Due to the 
challenges of the TST, we designed a score that could be 
used without testing for latent tuberculosis infection. 
Subesequently, we aimed to validate the risk score 
externally in an independent population.
Methods
Study design and participants
We did a prospective derivation study in Peru that used 
data from contacts of index cases of pulmonary tuber-
culosis in Ventanilla, an area characterised by desert 
shanty towns in the northern, coastal extension of Lima. 
This study was followed by an external validation study 
done in the urban coastal district of Callao, Lima. In both 
cohorts, index cases were patients registered with 
government-run health posts who had laboratory-
confirmed pulmonary tuberculosis. Contacts were indi-
viduals aged 15 years or older who had been in the same 
house as an index case for more than 6 h/week in the 
2 weeks before tuberculosis was diagnosed in the index 
case. Ethics approval was obtained from the Callao 
Ministry of Health, Lima, Asociación Benéfica PRISMA, 
Lima, and Imperial College London, London, UK. 
Derivation cohort
In 2002–06, we recruited participants from the 15 shanty- 
towns that comprise the Ventanilla district (figure 1). 
Ventanilla is an area of marked poverty, with many people 
living in wooden or adobe housing with poor access to 
essential services and utilities. We invited contacts of index 
cases to complete a baseline nurse assessment of 
tuberculosis risk factors (table 1, appendix p 1). Enrolled 
contacts were followed up until February, 2016, for 
tuberculosis. For the first 6 months of follow-up we visited 
households every 2 weeks, during which we offered free 
sputum smear or culture testing for contacts with 
tuberculosis symptoms. Thereafter we did household 
prevalence surveys roughly every 4 years, during which 
testing was also offered to all contacts. We also asked 
contacts to self-report tuberculosis diagnosed outside the 
study area. We ascertained tuberculosis diagnosed within 
the study area from health-post treatment registers.
Risk score derivation
For each year of follow-up, we calculated tuberculosis 
incidence per 100 person-years. We used Cox regression 
modelling to investigate factors associated with developing 
Research in context
Evidence before this study
We searched PubMed for studies published until April 30, 2017, 
with the search term “tuberculosis/risk [MesH] OR 
tuberculosis/prevention [MesH] OR tuberculosis/prediction 
[MesH] OR tuberculosis/score”. We found several reviews of 
tuberculosis contact investigation and preventive therapy that 
highlighted the low attention given to such interventions 
worldwide and emphasised the urgent need for scale-up if the 
objectives of WHO’s End TB Strategy are to be achieved. The low 
attention is particularly true for adults without HIV infection, 
who in our study setting and worldwide account for most 
tuberculosis disease among contacts. We found many studies 
and reviews characterising risk factors for tuberculosis, 
although only one attempted to define a method to predict 
tuberculosis risk in adults with assessment of a blood RNA 
signature. Tools that rely on invasive laboratory tests are 
promising but have limited potential for use in resource-
constrained settings, where much of the world’s tuberculosis 
occurs. 
Added value of this study
We derived and externally validated a score to predict the risk of 
tuberculosis in contacts aged 15 years or older of patients with 
laboratory-confirmed pulmonary tuberculosis. This risk score, 
which was based on nine clinical and demographic risk factors, 
accurately stratified contacts with large differences in 
tuberculosis risk, independently of tuberculin skin test results. 
Our risk score shows that while well nourished contacts living in 
well ventilated houses among residents with no history of 
tuberculosis and low exposure to the index tuberculosis case 
might have a predicted 10-year risk of one in 100, underweight 
contacts living in poorly ventilated houses among residents 
with a history of tuberculosis and substantial exposure to the 
index tuberculosis case might have a predicted 10-year risk of 
tuberculosis approaching one in three.
Implications of all the evidence
Despite advances in tuberculosis diagnosis and treatment, to 
reduce tuberculosis incidence worldwide, prevention of new 
cases in high-risk groups will need to be improved. Tuberculosis 
screening, preventive therapy, and surveillance of contacts are 
underused interventions. Our risk score could facilitate their 
scale-up through the identification of high-risk adult contacts of 
index cases, enabling these interventions to be more effectively 
targeted to those who are most likely to benefit. Integrated 
within the Community Randomised Evaluation of a 
Socioeconomic Intervention to Prevent TB study, we have 
started assessing whether targeted preventive therapy given 
based on this risk score, combined with socioeconomic support 
to empower access to care, can prevent tuberculosis among 
contacts.
See Online for appendix
Correspondence to: 
Dr Matthew J Saunders, 
Section of Infectious Diseases 
and Immunity, Imperial College 
London, Hammersmith Hospital 
Campus, Commonwealth 
Building, Level 8, 150 Du Cane 
Road, London W12 0NN, UK 
matthew.saunders@ifhad.org
Articles
1192 www.thelancet.com/infection   Vol 17   November 2017
tuberculosis and derive a continuous, integer-point risk 
score from the exact regression coefficients of the final 
model. We also assessed multiple interactions terms 
(table 2). We used whole numbers rather than exact 
regression coefficients to create an easily calculable score 
for field use. We arbitrarily defined low-risk, medium-risk, 
and high-risk groups and calculated each contact’s 10-year 
predicted tuberculosis risk with the the exact regression 
coefficients combined with the baseline survival function 
(appendix p 2).8 To assess the calibration of our integer 
score to a model that used exact regression coefficients, 
we derived the 10-year observed risk in risk groups and 
population deciles of the risk score from Kaplan-Meier 
functions and compared these with the mean 10-year 
predicted risks in each group or population decile. To 
assess the added value of including TST results in our 
score, we derived a multivariable model that included TST 
results and compared it with our final model. 
Risk score assessment and internal validation
We calculated the incidence for each risk group, plotted 
incidence trends, and calculated incidence rate ratios 
(IRRs) and 95% CIs. Kaplan-Meier functions were 
plotted to illustrate differences between risk groups in 
developing tuberculosis after 1, 2·5, 5, and 10 years, and 
were compared with the log-rank test (appendix p 3). We 
calculated Harrell’s c statistic to assess overall prediction 
of the continuous risk score. To validate the score 
internally, we repeatedly fitted the model with 
200 bootstrap samples and calculated the optimism-
adjusted c statistic (appendix p 3). We calculated the 
number of contacts needed to treat with preventive 
therapy in each risk group to prevent one case of 
tuberculosis over 5 years and 10 years, assuming that 
preventive therapy was 75% effective on an intention-to-
treat basis.9–11 Finally, because tuberculosis diagnosed in 
contacts within 6 months of the index case being 
diagnosed might not be preventable, we did a sensitivity 
analysis to assess the risk score excluding contacts who 
had started tuberculosis treatment within this time 
frame. All analyses were done with STATA (version 13) 
and all p values were two-sided.
External validation
The external validation was done in 17 urban communities 
in Callao, among participants recruited in 2014–15. This 
district has marked differences in population demo-
graphics, monetary poverty, and material living 
conditions from Ventanilla (figure 1).12 Index cases 
completed baseline nurse assessments in health posts to 
provide information on themselves, their households, 
and their contacts. We used these data to calculate a risk 
score for each contact (appendix p 3). Contacts were 
followed up with use of the health-post treatment 
Ventanilla risk-score derivation and internal validation
population, 2002–06
Landscape
Population in 2007
Tuberculosis case notification rate 2002–14*
Monetary poverty rate
Proportion of population with an unsatisfied basic need
Proportion living in a house with brick or concrete walls
Access to piped water inside the household
Desert, shanty towns
277 895
199 per 100 000 people
30%
23%
40%
54%
Callao risk-score external validation
population, 2014–15
Landscape
Population in 2015
Tuberculosis case notification rate 2014–15
Monetary poverty rate
Proportion of population with an unsatisfied basic need
Proportion living in a house with brick or concrete walls
Access to piped water inside the household
Urban
537 539
140 per 100 000 people
17%
9%
86%
93%
Peru
Ventanilla
Lima
Callao
Unstudied subdistricts
Figure 1: Characteristics of populations and study areas for the derivation and internal validation cohort and the external validation cohort
Statistics are reported by the Peruvian Instituto Nacional de Estadistica e Informatica unless indicated otherwise. *Collected collaboratively from government-run health posts. 
Articles
www.thelancet.com/infection   Vol 17   November 2017 1193
Ventanilla derivation 
cohort (n=2017)
Callao external-validation 
cohort (n=1910)
p value
Contacts
Age at recruitment (years) 30 (22–43) 38 (25–52) <0·0001*
High-risk age group (15–19 or >50 years) 602 (30%) 761 (40%) <0·0001
Men/women 814 (40%)/1203 (60%) 914 (48%)/996 (52%) <0·0001
Body-mass index (kg/m²)† 25·2 (4·2) 25·6 (3·9) 0·005‡
History of tuberculosis 222 (11%) 197 (10%) 0·5
Index cases
Age at recruitment (years) 26 (20–36) 28 (21–42) <0·0001*
Men/women 1210 (60%)/807 (40%) 1240 (65%)/670 (35%) 0·001
Sputum smear status <0·0001
Negative 53 (3%) 126 (7%)
1+ 726 (36%) 1104 (58%)
2+ 635 (31%) 402 (21%)
3+ 603 (30%) 278 (15%)
Drug sensitivity 0·004
Sensitive 1620 (80%) 1498 (78%)
Resistant to isoniazid 171 (9%) 223 (12%)
Multidrug resistant§ 226 (11%) 189 (10%)
Sustained exposure to index case¶ 1071 (53%) 1188 (62%) <0·0001
Migrant from coastal, mountainous, or jungle area of Peru 1054 (52%) 414 (22%) <0·0001
Households
Exposure to indoor air pollution|| 698 (35%) 20 (1%) <0·0001
Any household member with a history of tuberculosis 742 (37%) 801 (42%) 0·001
Fewer windows per room** 797 (40%) ·· ··
Wall material <0·0001
Adobe 223 (12%) 75 (4%)
Wood 842 (42%) 257 (13%)
Cement or brick 942 (47%) 1578 (83%)
Floor material <0·0001
Dirt 641 (32%) 105 (6%)
Cement 1212 (60%) 1301 (68%)
Tiles or laminated surface 164 (8%) 504 (26%)
Access to piped water inside the house 1049 (52%) 1852 (97%) <0·0001
Access to a toilet inside the house 972 (48%) 1851 (97%) <0·0001
Electric lighting 1911 (95%) 1868 (98%) <0·0001
Asset ownership <0·0001
Television 1859 (92%) 1865 (98%)
Stove 1979 (98%) 1843 (96%) 0·002
Fridge 988 (49%) 1604 (84%) <0·0001
Head of household did not complete secondary education 1155 (57%) 730 (38%) <0·0001
Data are median (IQR), number (%), or mean (SD). All p values stated represent χ² tests unless otherwise stated. See appendix pp 1–6 for a full description of these variables 
and the rationale for their definition. *Mann-Whitney U test. †Adjusted with WHO BMI-for-age charts (for ages 15, 16, 17, and 18 years, multiplied by 1·12, 1·09, 1·05, and 
1·02, respectively). ‡Two sample t test. §Defined by initial prescription of a multidrug-resistant tuberculosis regimen or by microbiological evidence of resistance to rifampicin 
and isoniazid. ¶≥5 h/day to index case in the 2 weeks before index case diagnosis (derivation cohort) or ≥60 h while index case had cough (validation cohort). ||Living in a 
household that cooked predominantly with kerosene (or occasionally solid fuels: wood, coal, animal dung, or crop wastes). **Defined as <0·67 windows per room in the 
derivation cohort; data not available for validation cohort and, therefore, to calculate a risk score for contacts we gave all participants an average value (appendix pp 1–3). 
Table 1: Characteristics of the derivation and external validation cohorts
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registers to obtain information on tuberculosis diagnoses 
until March 1, 2017. We used the same statistical methods 
as in the internal validation to validate the risk score 
externally.
Role of the funding source
The funders had no role in study design, data collection, 
data analysis, data interpretation, or writing of the report. 
The corresponding author had full access to all the data 
in the study and had final responsibility for the decision 
to submit for publication.
Results
Of 2682 contacts approached for inclusion in the 
derivation cohort, we recruited 2017 (75%, figure 2, 
table 1, appendix pp 4–6). The median age was 30 years 
and 40% of contacts were men (table 1). Among those not 
recruited, the median age was 28 years (IQR 21–42) and 
65% were men (95% CI 61–69). Contacts were followed 
up for a median of 10·7 years (IQR 9·5–11·8).
178 (9%) of 2017 contacts developed tuberculosis during 
19 147 person-years of follow-up, giving an incidence 
of 0·93 per 100 person-years (95% CI 0·80–1·08). Of 
these, 161 (90%) had microbiologically confirmed 
disease, were registered in health-post treatment 
registers, or both, and 17 were treated outside the health 
posts. The incidence was highest in the first 4 years after 
exposure, and was more than double the incidence in the 
local population for the duration of follow-up 
(appendix p 7).
Contacts who developed tuberculosis were independently 
more likely to have a low body-mass index, have previously 
had tuberculosis, be in a high-risk age group, have had 
sustained exposure to the index case, have had exposure to 
a male index case, be from a poorer household, have had 
exposure to indoor air pollution, have a household member 
with a history of tuberculosis, and live in a household with 
fewer windows per room  than those who did not develop 
tuberculosis (table 2, appendix pp 4–6). We found no 
2682 contacts approached
   16 ineligible
649 not recruited
2017 contacts followed up
2017 contacts included in model derivation
  200 hypothetical datasets (n=2017) 
    created by bootstrap resampling of 
    original cohort included in internal 
    validation
   715 index cases identified
2038 contacts approached
38 ineligible
90 had no data available to 
      calculate a risk score 
1910 contacts with data available to 
    calculate a risk score
1910 included in external validation
   631 index cases identified
Risk-score derivation and internal validation Risk-score external validation
Figure 2: Study profile
Unadjusted hazard ratio 
(95%CI)
Adjusted hazard ratio 
(95%CI)
p value Regression 
coefficient
Points assigned 
in risk score*
Contacts
BMI 0·87 (0·84–0·91) 0·87 (0·83–0·91) <0·0001 –0·138 Value of BMI
History of previous tuberculosis 2·0 (1·4–2·9) 1·8 (1·2–2·6) 0·005 0·566 –4
High-risk age group (15–19 or >50 years) 1·5 (1·1–2·0) 1·3 (0·96–1·8) 0·09 0·272 –2
Index cases
Sustained exposure to index case 1·6 (1·2–2·2) 1·8 (1·3–2·4) 0·0003 0·573 –4
Exposure to male index case 1·5 (1·0–2·1) 1·7 (1·2–2·4) 0·001 0·554 –4
Households
Lower community household 
socioeconomic position†
1·4 (1·0–2·0) 1·3 (0·95–1·8) 0·1 0·281 –2
Exposed to indoor air pollution 1·7 (1·3–2·4) 1·4 (0·97–1·9) 0·07 0·302 –2
Any household member with a history 
of tuberculosis
1·7 (1·2–2·3) 1·7 (1·2–2·3) 0·001 0·530 –4
Fewer windows per room 1·6 (1·1–2·2) 1·6 (1·2–2·2) 0·004 0·469 –3
The test of proportional hazards assumption for the entire model was χ2=7·27, p=0·61. BMI=body-mass index. *Calculated by multiplying the Cox regression coefficient by a 
constant (–7·25) and rounding to the nearest integer; the constant was chosen so that the exact BMI value could be used in the score, using the reciprocal (1/–0·138). 
†Measured with a household poverty index that combined 12 variables characterising education, access to services and material living conditions into a continuous variable 
that was dichotomised into two equal categories. The following interactions showed no significant associations and made no significant differences to the model when 
tested using the likelihood-ratio test, and, therefore, were excluded from the final model: sustained exposure and sex of index case (pinteraction=0·8); sex of index case and index 
case smear positivity status (pinteraction=0·7); exposure to indoor air pollution and fewer windows per room (pinteraction=0·5); sustained exposure and fewer windows per room 
(pinteraction=0·6); and sex of index case and socioeconomic position (pinteraction=0·07). Among the household characteristics, the only significant associations were between 
exposure to indoor air pollution and socioeconomic position (p<0·0001); exposure to indoor air pollution and fewer windows per room (p=0·0003); and indoor air pollution 
and any household member with a history of tuberculosis (p<0·0001). 
Table 2: Multivariable Cox regression analysis of factors associated with tuberculosis in the derivation cohort
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significant interactions between variables but did note 
some associations between household characteristics 
(table 2).
When the regression coefficients and number of 
integer points assigned to each variable were set 
(table 2), the score ranges for low, medium, and high 
risk were set at 19 points or more, 12–18 points, and 
11 points or fewer, respectively. An example risk score 
form is shown in figure 3. Therefore, 601 (30%) contacts 
were assigned as low risk, 881 (44%) as medium risk, 
and 535 (27%) as high risk (figure 3). Of the 178 contacts 
who developed tuberculosis, 17 (10%) were in the low-
risk group, 54 (30%) in the medium-risk group, and 
107 (60%) in the high-risk group. The 10-year observed 
risk in the risk groups and population deciles was 
similar to that predicted with exact regression 
coefficients (appendix p 8).
Trends in the incidence of tuberculosis for each 
risk group are shown in the appendix (p 7). The IRR for 
the high-risk group versus the low-risk group was 
8·1 (95% CI 4·8–14, p<0·0001), for the high-risk group 
versus the medium-risk group was 3·6 (2·6–5·1, 
p<0·0001), and for the medium-risk group versus the 
low-risk group was 2·2 (1·3–4·1, p=0·003). The 10-year 
observed risks in the low-risk, medium-risk, and high-
risk groups were 2·8% (95% CI 1·7–4·4), 6·2% (4·8–8·1), 
and 20·6% (17·3–24·4), respectively (log-rank p<0·0001; 
figure 4, appendix p 9). The c statistic was 0·72, and after 
bootstrap resampling internal validation the optimism-
adjusted c statistic was 0·71. The risk score predicted risk 
similarly for contacts of index cases with drug-sensitive 
tuber culosis (c statistic 0·71) and tuber culosis resistant to 
isoniazid, rifampicin, or both (c statistic 0·73). In the 
sensitivity analysis that excluded contacts diagnosed 
as having tuberculosis within 6 months of the index case 
being diagnosed, the 10-year observed risks in the 
low-risk, medium-risk, and high-risk groups were, 
respectively, 2·1% (95% CI 1·2–3·7), 4·8% (3·5–6·7), 
and 17·8% (14·7–21·6; c statistic 0·74, log-rank p<0·0001; 
appendix p 10).
With the assumption of 75% effectiveness of preventive 
therapy,9–11 the numbers needed to treat to prevent one 
case of tuberculosis over 10 years in the low-risk, 
medium-risk, and high-risk groups were 48, 22, and six, 
respectively (figure 3). To prevent one case over 5 years, 
the corresponding numbers needed to treat were 67, 32, 
and eight.
The proportions of contacts who had positive TST 
results did not differ significantly between risk groups 
(p=0·13, figure 5). Within each group, there were no 
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Risk score
B
C
A
Low risk
Medium risk
High risk
10-year risk of tuberculosis
Low-risk score (n=601)
Observed 10-year risk 2·8%
Number needed to treat 48
Medium-risk score (n=881)
Observed 10-year risk 6·2%
Number needed to treat 22
High-risk score (n=535)
Observed 10-year risk 20·6%
Number needed to treat 6
Contact factors
1. Calculate body-mass index using provided charts or the formula. 
2. Has this person had tuberculosis before?   
3. Is this person aged 15–19 or >50 years? 
Index factors
4. Has this person spent ≥5 h/day in the same room as the index case in the
     past 2 weeks? 
5. Is the index case a man?  
Household factors
6. Is this person a member of a household that is in the poorer half of all households
     in the community?
7.  Does this household cook with wood, coal, dung, crop wastes, or kerosene? 
8. Has any other member of the household, including the index case, ever had
     tuberculosis before this episode? 
9. Does this household have a low number of windows per room?  Subtract points
      if household has: 0 windows, <2 windows if 2 or 3 rooms, <3 windows if
      4 rooms,  <4 windows if 5 or 6 rooms.
  
Low risk ≥19 points    Medium risk 12–18 points High risk ≤11 points
Risk score
running
total
(weight/height2)
Yes: subtract 4
Yes: subtract 2
Yes: subtract 4
Yes: subtract 4
Yes: subtract 2
Yes: subtract 2
Yes: subtract 4
 Yes: subtract 3
Grand total
Figure 3: A score to predict risk of tuberculosis in adult contacts of index cases
(A) An example risk score for field use. (B) Predicted 10-year risk of tuberculosis 
plotted against risk scores. (C) Numbers needed to treat with preventive therapy to 
prevent one case of tuberculosis among contacts, by risk group. 
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significant differences in tuberculosis risk when 
stratified by TST result (figure 5). Within each TST result 
(negative, positive, or unknown), our risk score stratified 
contacts with significantly different tuberculosis 
risks (log-rank p<0·0001 for each TST result). In a 
multivariable model including TST results, compared 
with unknown results, no increased risk of developing 
tuberculosis was seen for contacts with negative results 
(adjusted hazard ratio 0·64, p=0·1) or positive results 
(1·1, p=0·5). As expected, however, TST-positive contacts 
were more likely to develop tuberculosis than TST-
negative contacts (1·8, p=0·02; appendix p 11). Including 
TST results added little predictive value to our risk 
model (c statistic 0·73 vs 0·72 for the original model).
For the external validation, we recruited 631 index cases 
and identified 2000 contacts aged 15 years or older. Of 
these, 1910 (96%) had data available to calculate risk 
scores. Contacts were followed up for a median 2·0 years 
(IQR 1·6–2·4). The characteristics of these contacts 
differed significantly from those in the derivation cohort, 
particularly for material living conditions (table 1).
Overall, 65 (3%) of 1910 contacts developed tuberculosis 
during 3771 person-years of follow-up, giving an overall 
incidence of 1·7 per 100 person-years (95% CI 1·4–2·2). 
575 (30%) were classified as low risk, 918 (48%) as medium 
risk, and 417 (22%) as high risk. The observed risks 
of tuberculosis at 2·5 years for these risk groups 
were 1·4% (95% CI 0·70–2·8), 3·9% (2·5–5·9), and 8·6% 
(5·9–12·6), respectively, and the c statistic was 0·67 (log-
rank p<0·0001; figure 4, appendix p 9). In a sensitivity 
analysis excluding cases diagnosed within 6 months of the 
index case being diagnosed, the 2·5-year observed risks in 
the low-risk, medium-risk, and high-risk groups were 0·18% 
(95% CI 0·02–1·2), 2·8% (1·6–4·8), and 6·4% (4·0–10), 
respectively, with a c statistic of 0·75 (log-rank p<0·0001, 
appendix p 10). Our risk score generally performed well 
compared with the predicted risk derived from exact 
regression coefficients, although among contacts with 
higher scores, the observed 2·5-year risk was marginally 
lower than the predicted risk (appendix p 12).
Discussion
In this study of adult contacts of pulmonary tuberculosis 
index cases from two independent cohorts in Peru, 
we derived and externally validated a risk score that 
effectively stratified contacts with significantly different 
risks of developing tuberculosis. Our score uses data 
on nine clinical and demographic factors that can be 
readily collected and that predicted tuberculosis risk 
independently of TST results. This simple integer-point 
risk score, which facilitates implementation in the field, 
yielded results with similar accuracy to those derived 
from exact regression coefficients. Therefore, we were 
able to predict risk of developing tuberculosis for at least 
10 years after exposure without any laboratory or invasive 
testing. Use of this risk score could allow a paradigm 
shift from the current approach of one size fits all to 
individual-level contact investigation, and might facilitate 
targeted screening, surveillance, and preventive therapy 
for adult contacts who are most likely to benefit. This 
approach could furthermore reduce the number needed 
to treat with preventive therapy and potentially improve 
the effects of these interventions, especially in resource-
constrained settings.
Preventive therapy provided after tuberculosis exposure 
and as part of a comprehensive HIV care package is a 
core component of the WHO End TB Strategy.6 It 
provides robust and sustained protection, especially to 
individuals without HIV, not only to the recipient but 
also to individuals at risk of secondary transmission.4 In 
Alaska, USA, where tuberculosis was endemic in the 
1950s, the effects of preventive therapy were sustained 
for at least 20 years.13 In Brazil, the THRio study showed 
that 6 months of preventive therapy had 83% efficacy in 
HIV-infected individuals for at least 7 years.14 In a setting 
such as Peru, which has medium tuberculosis incidence 
and low HIV prevalence and is epidemiologically similar 
to Alaska in the 1950s, preventive therapy after exposure 
has the potential to confer long-term protection to 
contacts at high risk of tuberculosis, and is likely 
to become a priority for the national tuberculosis 
programme as control efforts focus increasingly on 
prevention. Of note, our score includes adults whose risk 
of hepatitis related to preventive therapy increases 
with age.10 Implementing our score should improve the 
risk-to-benefit ratio and allow the risks, costs, and incon-
veniences to be better informed and, hence, re stricted to 
the recipients who will benefit most.
Our risk groups were arbitrarily defined for this study. 
In practice, the risk score could be used with different 
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Figure 4: Cumulative observed risk of tuberculosis among contacts, stratified by risk group
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cutoffs depending on contact and prescriber preferences 
and the availability of resources. Given the high overall 
risk of tuberculosis in the two cohorts we assessed, our 
findings might also support the conclusion that 
preventive therapy should be given to all contacts, but 
with prioritisation of those in the high-risk group. 
Furthermore, the differences in early tuberculosis inci-
dence between risk groups (appendix p 7) highlight a role 
for our score as an adjunct to prioritise screening, 
educational interventions, and future surveillance for 
contacts at highest risk. In a previous study, a similar 
algorithm was derived to predict risk of tuberculosis 
among child contacts, but relied on TST results and was 
hindered by the uncertainty of diagnosing tuberculosis 
in children.15 Another study described a simple algorithm 
that incorporated exposure variables into a score to 
predict latent tuberculosis among children younger than 
15 years, which might facilitate targeted preventive 
therapy.16 A further study derived and validated a blood 
RNA signature for predicting tuberculosis among 
adolescents and adults.17 Although the results were 
promising, the gene signature only had predictive ability 
for up to 18 months, and the technology and infrastructure 
required are unlikely to be feasible for implementation 
in resource-constrained settings. By contrast, our risk 
score predicted risk of developing tuberculosis with 
similar accuracy but for at least 10 years after exposure.
In our derivation cohort, positive TST results were 
common and had similar frequency in all three risk 
groups. In high-incidence settings, TST has reduced 
specificity and limited power as a predictor of 
tuberculosis.18 Furthermore, TST might show false-
negative results in people at the highest risk of 
developing tuberculosis, such as those who are 
undernourished or have HIV, and false-positive results 
in people who have received BCG vaccinations.19,20 We 
chose not to include TST results in our model because 
these limitations are exacerbated by operational barriers, 
including needing trained staff to do the test, repeated 
clinic visits, and reduced availability in resource-
constrained settings.3,5 We believe this approach is 
justified because the addition of TST results to the model 
did not significantly improve its predictive power. 
Importantly, our score accurately stratified contacts with 
differing risks of tuberculosis independently of TST 
results.
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The variables that make up our score include several 
established risk factors for developing tuberculosis and 
highlight the complex relations between tuberculosis risk 
and characteristics of contacts, index cases, and 
households.7 Our results corroborate findings from a 
meta-analysis that showed a consistent log-linear relation 
between body-mass index and tuberculosis incidence.21 
Sustained exposure to the index case and the contact 
having previous tuberculosis are both well established as 
risk factors for developing tuberculosis, particularly in 
child contacts.16 We found associations between risk of 
developing tuberculosis and age being 15–19 years or 
50 years or older. These results are similar to the national 
and regional data in Peru on tuberculosis incidence.22 
Operationally, users of our score are required to determine 
whether a contact is from the poorer half of households in 
the community. Although socioeconomic position will 
vary between settings, users could be assisted in making 
this assessment by using a setting-specific poverty index 
similar to the ones we used. Moreover, as WHO places 
increasing emphasis on documenting tuberculosis-related 
costs, the process of defining socioeconomic position is 
likely to become more clearly defined.23 Our study adds to 
the evidence suggesting that exposure to indoor air 
pollution and living in poorly ventilated households 
increase the risk of developing tuber culosis.24,25 A strength 
of our assessment is that we did not use expensive 
equipment to quantify exposure to particulates or 
ventilation and, therefore, our operational definitions 
reflect real-world data that a tuberculosis programme 
could realistically collect. On a broader level, government 
departments might target these risk factors directly 
through providing clean cooking stoves and fuel, education 
on maintaining ventilation, and, ultimately, improved 
housing to communities with a high tuberculosis burden. 
Global tuberculosis control efforts aim to improve the 
diagnosis and prevention of all cases of tuberculosis, 
irrespective of the primary source of infection. 
Therefore, we did not use molecular techniques to 
identify tuberculosis strains and confirm transmission 
from index cases to contacts because we believed it 
would not affect our conclusions. Although we did not 
confirm transmission, we found that index case smear-
positivity grade, and self-reported cough frequency did 
not predict risk of tuberculosis in contacts (appendix 
pp 4–6). Our findings suggest that these measures are 
unreliable markers of infectiousness and support the 
use of objective acoustic parameters, such as cough 
monitors, viability microscopy, and cough aerosol 
cultures, to assess infectiousness in future research.26,27 
In contrast to previously published data,28 we found no 
evidence that contacts of index cases of multidrug-
resistant tuberculosis were at lower risk than contacts 
of index cases of drug-sensitive tuberculosis. 
Furthermore, the high burden of tuberculosis seen 
among contacts of index cases with multidrug-resistant 
tuberculosis highlights the importance of long-term 
surveillance and use of available preventive therapy to 
reduce ongoing community transmission.
Other strengths of this study include comprehensive 
follow-up to ascertain diagnosis of tuberculosis, robust 
internal validation, and subsequent external validation 
in a distinct population with different tuberculosis 
epidem iology at a different time. Importantly, the risk 
factors included in our model have documented 
associations with tubercu losis across diverse locations, 
including high-income countries,29,30 which suggests that 
the score will be adaptable across a broad range of 
settings. Limitations of our study include a risk of 
selection bias in the derivation cohort, although the 
likelihood of bias was reduced by most contacts being 
followed up and subsequent high numbers of contacts 
being recruited in the external validation cohort. We 
were unable to assess how risk factors changed with 
time and did not collect data from contacts on subsequent 
tuberculosis exposures. However, these data were not 
desirable for our objectives as we aimed to derive a tool 
specifically for use during initial contact investigation. 
Furthermore, we did not perfectly characterise all 
established risk factors for developing tuberculosis and 
could detect no association with comorbidities and 
tuberculosis, perhaps because self-reporting 
comorbidities might have underestimated their 
prevalence. Although our HIV data were limited due to 
universal testing not being available, population 
prevalence was low31 and was unlikely to have 
significantly affected our results. Importantly, HIV-
infected individ uals and those with diabetes are already 
prioritised for interventions and, therefore, our score 
does not discrim inate against these people but acts as an 
adjunct to identify others at high risk. Finally, the data 
used in our external validation cohort were reported by 
the index case, including estimates of contact weight 
and height, which reflects the operational data that 
might be collected by health-care staff during routine 
contact investigation. We did not have data available on 
windows per room, and our variable characterising 
sustained exposure to the index case was defined 
differently from that used in the derivation cohort. 
Despite these differences, the score had good 
discrimination under operational conditions in the 
external validation cohort, whether including or 
excluding contacts diagnosed as having tuberculosis 
within 6 months of the index case being diagnosed. 
Although the observed risk among contacts in the high-
risk group was slightly lower in the validation cohort 
than the predicted risk, this difference might have 
arisen because ascertainment only included cases 
identified through health-post treatment registers 
without household visits. Overall, however, our derived 
and externally validated risk score offers an intuitive and 
practical tool for initial contact investigations to stratify 
adult contacts and identify those at the highest risk of 
developing tuberculosis.
Articles
www.thelancet.com/infection   Vol 17   November 2017 1199
Contributors
MJS, TW, MAT, LHM, RHG, and CAE conceived the study. MRB, KZ, 
RM, TRV, and CAE collected the data. MJS, MAT, and CAE analysed the 
data. MJS, TW, MAT, MRB, SD, JSF, LHM, RHG, and CAE interpreted 
the paper. All authors participated in the preparation and approval of the 
Article.
Declaration of interests
We declare no competing interests.
Acknowledgments
This study was supported by Wellcome Trust awards 057434/Z/99/B 
(MAT, KZ, RM, TRV, JSF, RHG, and CAE), Z070005/Z/02/Z (MAT, TRV, 
JSF, RHG, and CAE), 078340/Z/05/Z (MAT, KZ, RM, TRV, JSF, and 
RHG, CAE), 105788/Z/14/Z (SD, RHG, and CAE), 201251/Z/16/Z (MJS, 
RHG, and CAE), the Department for International Development Civil 
Society Challenge Fund (MAT, KZ, RM, TRV, CAE), the Joint Global 
Health Trials consortium (Medical Research Council, Department for 
International Development, and Wellcome Trust award MR/K007467/1 
[TW, MAT, KZ, RM, TRV, RHG, and CAE]), the Bill & Melinda Gates 
Foundation (award OPP1118545 [TW, MAT, RM, TRV, and CAE]), 
Imperial College National Institutes of Health Research Biomedical 
Research Centre (JAF and CAE), the Foundation for Innovative New 
Diagnostics (MAT, KZ, TRV, and CAE), the Sir Halley Stewart Trust 
(CAE), WHO (CAE), the STOP TB partnership’s TB REACH initiative 
funded by the Government of Canada (W5_PER_CDT1_PRISMA [MAT, 
RM, and CAE]), and Innovation For Health And Development (MJS, TW, 
and CAE)
References
1 Fox GJ, Barry SE, Britton WJ, Marks GB. Contact investigation for 
tuberculosis: a systematic review and meta-analysis. 
Eur Respir J 2013; 41: 140–56.
2 WHO. Recommendations for investigating contacts of persons with 
infectious tuberculosis in low- and middle-income countries. 
Geneva: World Health Organization, 2012.
3 Alsdurf H, Hill PC, Matteelli A, Getahun H, Menzies D. 
The cascade of care in diagnosis and treatment of latent 
tuberculosis infection: a systematic review and meta-analysis. 
Lancet Infect Dis 2016; 16: 1269–78.
4 Rangaka MX, Cavalcante SC, Marais BJ, et al. Controlling the 
seedbeds of tuberculosis: diagnosis and treatment of tuberculosis 
infection. Lancet 2015; 386: 2344–53.
5 Tebruegge M, Bogyi M, Soriano-Arandes A, Kampmann B. 
Shortage of purified protein derivative for tuberculosis testing. 
Lancet 2014; 384: 2026.
6 Uplekar M, Weil D, Lonnroth K, et al. WHO’s new End TB Strategy. 
Lancet 2015; 385: 1799–801.
7 Saunders MJ, Datta S. Contact investigation: a priority for tuberculosis 
control programs. Am J Respir Crit Care Med 2016; 194: 1049–50.
8 Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, 
Brindle P. Derivation and validation of QRISK, a new 
cardiovascular disease risk score for the United Kingdom: 
prospective open cohort study. BMJ 2007; 335: 136.
9 WHO. Guidelines on the management of latent tuberculosis 
infection. Geneva: World Health Organization, 2015.
10 Smieja M, Marchetti C, Cook D, Smaill F. Isoniazid for preventing 
tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev 
1999; 1: CD001363.
11 Sterling T, Villarine ME, Borisov A, et al. Three months of rifapentine 
and isoniazid for latent tuberculosis infection. N Engl J Med 2011; 
365: 683–93.
12 Instituto Nacional de Estadística e Informática. Crecimiento 
Económico, Población, Características Sociales y Seguridad 
Ciudadana en la Provincia Constitucional del Callao. Lima: Instituto 
Nacional de Estadística e Informática, 2016.
13 Comstock G, Baum C, Snider DJ. Isoniazid prophylaxis among 
Alaskan Eskimos: a final report of the bethel isoniazid studies. 
Am Rev Respir Dis 1979; 119: 827–30.
14 Golub JE, Cohn S, Saraceni V, et al. Long-term protection from 
isoniazid preventive therapy for tuberculosis in HIV-infected 
patients in a medium-burden tuberculosis setting: the TB/HIV in 
Rio (THRio) study. Clin Infect Dis 2015; 60: 639–45.
15 Chan PC, Peng SSF, Chiou MY, et al. Risk for tuberculosis in child 
contacts: development and validation of a predictive score. 
Am J Respir Crit Care Med 2014; 189: 203–13.
16 Mandalakas AM, Kirchner HL, Lombard C, et al. Well-quantified 
tuberculosis exposure is a reliable surrogate measure of tuberculosis 
infection. Int J Tuberc Lung Dis 2012; 16: 1033–39.
17 Zak DE, Penn-Nicholson A, Scriba TJ, et al. A blood RNA signature 
for tuberculosis disease risk: a prospective cohort study. Lancet 2016; 
387: 2312–22.
18 Rangaka MX, Wilkinson KA, Glynn JR, et al. Predictive value of 
interferon-γ release assays for incident active tuberculosis: 
a systematic review and meta-analysis. Lancet Infect Dis 2012; 
12: 45–55.
19 Pelly TF, Santillan CF, Gilman RH, et al. Tuberculosis skin testing, 
anergy and protein malnutrition in Peru. Int J Tuberc Lung Dis 2005; 
9: 977–84.
20 Shanaube K, Hargreaves J, Fielding K, et al. Risk factors associated 
with positive quantiFERON-TB gold in-tube and tuberculin skin 
tests results in Zambia and South Africa. PLoS One 2011; 6: e18206.
21 Lönnroth K, Williams BG, Cegielski P, Dye C. A consistent 
log-linear relationship between tuberculosis incidence and body 
mass index. Int J Epidemiol 2010; 39: 149–55.
22 WHO. Tuberculosis in the Americas: regional report. 
Geneva: World Health Organization, 2014.
23 Wingfield T, Boccia D, Tovar M, et al. Defining catastrophic costs 
and comparing their importance for adverse tuberculosis outcome 
with multi-drug resistance: a prospective cohort study, Peru. 
PLoS Med 2014; 11: e1001675.
24 Lin HH, Ezzati M, Murray M. Tobacco smoke, indoor air pollution 
and tuberculosis: a systematic review and meta-analysis. 
PLoS Med 2007; 4: e20.
25 Escombe AR, Oeser CC, Gilman RH, et al. Natural ventilation for 
the prevention of airborne contagion. PLoS Med 2007; 4: e68.
26 Datta S, Sherman JM, Bravard MA, Valencia T, Gilman RH, 
Evans CA. Clinical evaluation of tuberculosis viability microscopy 
for assessing treatment response. Clin Infect Dis 2015; 60: 1186–95.
27 Jones-Lopez EC, Namugga O, Mumbowa F, et al. Cough aerosols of 
Mycobacterium tuberculosis predict new infection a household 
contact study. Am J Respir Crit Care Med 2013; 187: 1007–15.
28 Grandjean L, Gilman RH, Martin L, et al. Transmission of 
multidrug-resistant and drug-susceptible tuberculosis within 
households: a prospective cohort study. PLoS Med 2015; 12: e1001843.
29 Morán-Mendoza O, Marion SA, Elwood K, Patrick D, FitzGerald JM. 
Risk factors for developing tuberculosis: a 12-year follow-up of 
contacts of tuberculosis cases. Int J Tuberc Lung Dis 2010; 14: 1112–19.
30 Saunders MJ, Koh GCKW, Small A, Dedicoat M. Predictors of 
contact tracing completion and outcomes in tuberculosis: a 21-year 
retrospective cohort study. Int J Tuberc Lung Dis 2014; 18: 640–46.
31 Pun M. Situacion de la Epidemia de VIH en el Peru. Nov 28, 2015. 
https://www.minsa.gob.pe/portada/Especiales/2015/vih/matcom/
Situacion-Epidemiologica-VIH-2015.pdf (accessed Dec 21, 2016)
